UB Paderborn / Katalog / Suche / in CDI

689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A781-A781

2023

Volltextzugriff (PDF)

P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e5193345-n/a

2023

Volltextzugriff (PDF)

P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MONUMENTAL‐1

HemaSphere, 2023-08, Vol.7 (S3), p.e646904e-n/a

2023

Volltextzugriff (PDF)

High-Risk Gene Expression Subtype Provides Molecular Basis for Different Clinical Presentation of Primary and Secondary Plasma Cell Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.726-726

2021

Volltextzugriff (PDF)

Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment

Leukemia research, 2021-12, Vol.111, p.106687-106687, Article 106687

2021

Volltextzugriff (PDF)

CD33 Is Expressed in a Significant Subset of Multiple Myeloma Patients in the US and May Represent a Viable Therapeutic Target

Blood, 2017-12, Vol.130, p.5378-5378

2017

Volltextzugriff (PDF)

The Rhesus Macaque (Macaca mulatta) Sperm Proteome

Molecular & cellular proteomics, 2013-11, Vol.12 (11), p.3052-3067

2013

Volltextzugriff (PDF)

Identification and characterization of the zebra finch (Taeniopygia guttata) sperm proteome

Journal of proteomics, 2019-02, Vol.193, p.192-204

2019

Volltextzugriff (PDF)

NSP-04 Managing infections, hypogammaglobulinemia, and neutropenia during treatment with teclistamab in relapsed/refractory multiple myeloma: nurse-led experience from the MajesTEC-1 study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S315-S315

2023

Volltextzugriff (PDF)

Identification and characterization of the zebra finch (Taeniopygia guttata) sperm proteome

Journal of proteomics, 2018

2018

Volltextzugriff (PDF)

Molecular Characterization of Bone Marrow and Peripheral Blood Compartments from Patients with Plasma Cell Leukemia in the Mmrf Commpass Study

Blood, 2019-11, Vol.134 (Supplement_1), p.1782-1782

2019

Volltextzugriff (PDF)

Unsupervised Clustering of DNA Copy Number Profiles Identifies a High-Risk Subtype of Hyperdiploid Multiple Myeloma: An Mmrf Commpass Analysis

Blood, 2019-11, Vol.134 (Supplement_1), p.1805-1805

2019

Volltextzugriff (PDF)

Multiple Myeloma Epigenetic Programming Prognostic of Outcome Converges with Loci Reprogrammed in Relapsed/Refractory Disease

Blood, 2019-11, Vol.134 (Supplement_1), p.858-858

2019

Volltextzugriff (PDF)

Abstract 839: Whole genome DNA methylation analysis of multiple myeloma identifies pervasive hypomethylation and biomarkers of survival

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.839-839

2019

Volltextzugriff (PDF)

An Integrated Genomics Analysis Identifies Recurrent Gain- and Loss-of-Function Events and in Distinct Subtypes of Multiple Myeloma

Blood, 2018-11, Vol.132 (Supplement 1), p.113-113

2018

Volltextzugriff (PDF)

DNA methylation reprogramming in relapsed/refractory myeloma converges with loci prognostic of survival in newly diagnosed patients

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e57-e57

2019

Volltextzugriff (PDF)

Identification and Molecular Characterization of High-Risk Multiple Myeloma Patients from the MMRF CoMMpass Study at Diagnosis and Progression

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e7-e7

2019

Volltextzugriff (PDF)

Integrative Analysis of the Genomic Landscape Underlying Multiple Myeloma at Diagnosis: An Mmrf Commpass Analysis

Blood, 2017-12, Vol.130, p.326-326

2017

Volltextzugriff (PDF)

Analysis of Sequential Patient Samples from the Mmrf Commpass Study Identifies a High Risk Progression Phenotype

Blood, 2018-11, Vol.132 (Supplement 1), p.111-111

2018

Volltextzugriff (PDF)

Development and Validation of a High Risk Multiple Myeloma Gene Expression Index from RNA Sequencing: An Mmrf Commpass Analysis

Blood, 2018-11, Vol.132 (Supplement 1), p.1895-1895

2018

Volltextzugriff (PDF)

POSTER: MM-191 Analysis of Infections and Parameters of Humoral Immunity in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Talquetamab (tal) Monotherapy in MonumenTAL-1

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S225-S225

2023

Volltextzugriff (PDF)

MM-191 Analysis of Infections and Parameters of Humoral Immunity in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Talquetamab (tal) Monotherapy in MonumenTAL-1

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S480-S480

2023

Volltextzugriff (PDF)

Abstract 3006: Molecular characterization of baseline and serial multiple myeloma patients from the MMRF CoMMpass study

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3006-3006

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2

P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS

P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MONUMENTAL‐1

High-Risk Gene Expression Subtype Provides Molecular Basis for Different Clinical Presentation of Primary and Secondary Plasma Cell Leukemia

Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment

CD33 Is Expressed in a Significant Subset of Multiple Myeloma Patients in the US and May Represent a Viable Therapeutic Target

The Rhesus Macaque (Macaca mulatta) Sperm Proteome

Identification and characterization of the zebra finch (Taeniopygia guttata) sperm proteome

NSP-04 Managing infections, hypogammaglobulinemia, and neutropenia during treatment with teclistamab in relapsed/refractory multiple myeloma: nurse-led experience from the MajesTEC-1 study

Identification and characterization of the zebra finch (Taeniopygia guttata) sperm proteome

Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Correlative Analyses from MajesTEC-1

Molecular Characterization of Bone Marrow and Peripheral Blood Compartments from Patients with Plasma Cell Leukemia in the Mmrf Commpass Study

Unsupervised Clustering of DNA Copy Number Profiles Identifies a High-Risk Subtype of Hyperdiploid Multiple Myeloma: An Mmrf Commpass Analysis

Multiple Myeloma Epigenetic Programming Prognostic of Outcome Converges with Loci Reprogrammed in Relapsed/Refractory Disease

Abstract 839: Whole genome DNA methylation analysis of multiple myeloma identifies pervasive hypomethylation and biomarkers of survival

An Integrated Genomics Analysis Identifies Recurrent Gain- and Loss-of-Function Events and in Distinct Subtypes of Multiple Myeloma

Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma

DNA methylation reprogramming in relapsed/refractory myeloma converges with loci prognostic of survival in newly diagnosed patients

Identification and Molecular Characterization of High-Risk Multiple Myeloma Patients from the MMRF CoMMpass Study at Diagnosis and Progression

Integrative Analysis of the Genomic Landscape Underlying Multiple Myeloma at Diagnosis: An Mmrf Commpass Analysis

Analysis of Sequential Patient Samples from the Mmrf Commpass Study Identifies a High Risk Progression Phenotype

Development and Validation of a High Risk Multiple Myeloma Gene Expression Index from RNA Sequencing: An Mmrf Commpass Analysis

POSTER: MM-191 Analysis of Infections and Parameters of Humoral Immunity in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Talquetamab (tal) Monotherapy in MonumenTAL-1

MM-191 Analysis of Infections and Parameters of Humoral Immunity in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With Talquetamab (tal) Monotherapy in MonumenTAL-1

Abstract 3006: Molecular characterization of baseline and serial multiple myeloma patients from the MMRF CoMMpass study

Aktive Filter

Suchergebnisse filtern